IMP
Process View
positive regulation of acute inflammatory response
Any process that activates or increases the frequency, rate, or extent of an acute inflammatory response.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of acute inflammatory response"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| IL8 | interleukin 8 | 1.000 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 1.000 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.999 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.997 | ||
| IL1B | interleukin 1, beta | 0.991 | Mouse | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.988 | ||
| SYK | spleen tyrosine kinase | 0.988 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.976 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.970 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.963 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.959 | Mouse Rat | |
| IL1R1 | interleukin 1 receptor, type I | 0.959 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.959 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.921 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.822 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.731 | Mouse | |
| ICAM1 | intercellular adhesion molecule 1 | 0.708 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.706 | Mouse | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.673 | ||
| BCL2A1 | BCL2-related protein A1 | 0.635 | ||
| SRGN | serglycin | 0.610 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.585 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.576 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.512 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.508 | ||
| CFH | complement factor H | 0.448 | ||
| PLEK | pleckstrin | 0.446 | ||
| IER3 | immediate early response 3 | 0.401 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.325 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.324 | ||
| PTX3 | pentraxin 3, long | 0.315 | ||
| CFI | complement factor I | 0.310 | ||
| IL6R | interleukin 6 receptor | 0.299 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.299 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.257 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.251 | ||
| IL7R | interleukin 7 receptor | 0.238 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.232 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.226 | ||
| TLR2 | toll-like receptor 2 | 0.217 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.209 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.202 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.193 | ||
| C1S | complement component 1, s subcomponent | 0.180 | ||
| SLA | Src-like-adaptor | 0.177 | ||
| CD163 | CD163 molecule | 0.173 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.169 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.167 | ||
| BLNK | B-cell linker | 0.167 | ||
| CFB | complement factor B | 0.166 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.162 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.162 | ||
| C3AR1 | complement component 3a receptor 1 | 0.162 | ||
| OSMR | oncostatin M receptor | 0.139 | ||
| SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.135 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.134 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.128 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.120 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.119 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.119 | ||
| INHBA | inhibin, beta A | 0.119 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.117 | ||
| S100A8 | S100 calcium binding protein A8 | 0.116 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.115 | ||
| TYROBP | TYRO protein tyrosine kinase binding protein | 0.113 | ||
| CD53 | CD53 molecule | 0.106 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.106 | ||
| RNASE6 | ribonuclease, RNase A family, k6 | 0.101 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.099 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.097 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.096 | ||
| NNMT | nicotinamide N-methyltransferase | 0.095 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.094 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.094 | ||
| S100A9 | S100 calcium binding protein A9 | 0.091 | ||
| KNG1 | kininogen 1 | 0.091 | ||
| LMO4 | LIM domain only 4 | 0.090 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.089 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.088 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.088 | ||
| CD83 | CD83 molecule | 0.088 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.087 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.085 | ||
| HCK | hemopoietic cell kinase | 0.084 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.082 | ||
| THBS1 | thrombospondin 1 | 0.081 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.080 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.074 | ||
| TNC | tenascin C | 0.070 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.070 | ||
| ALOX5AP | arachidonate 5-lipoxygenase-activating protein | 0.068 | Rat | |
| ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | 0.067 | ||
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.066 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.066 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.063 | ||
| SELE | selectin E | 0.062 | ||
| AQP9 | aquaporin 9 | 0.062 | ||
| RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.061 | ||
| C5AR1 | complement component 5a receptor 1 | 0.061 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.060 | ||
| C1R | complement component 1, r subcomponent | 0.059 | ||
| TNF | tumor necrosis factor | 0.058 | ||
| GPR109B | G protein-coupled receptor 109B | 0.058 | ||
| GPR65 | G protein-coupled receptor 65 | 0.057 | ||
| STC1 | stanniocalcin 1 | 0.057 | ||
| CLEC7A | C-type lectin domain family 7, member A | 0.057 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.057 | ||
| CPA3 | carboxypeptidase A3 (mast cell) | 0.056 | ||
| EMP1 | epithelial membrane protein 1 | 0.056 | ||
| ALOX5 | arachidonate 5-lipoxygenase | 0.051 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.051 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.050 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.050 | ||
| G0S2 | G0/G1switch 2 | 0.047 | ||
| EGR2 | early growth response 2 | 0.047 | ||
| PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 0.046 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.046 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.046 | ||
| MNDA | myeloid cell nuclear differentiation antigen | 0.045 | ||
| CH25H | cholesterol 25-hydroxylase | 0.043 | ||
| LY96 | lymphocyte antigen 96 | 0.043 | ||
| HRH1 | histamine receptor H1 | 0.043 | ||
| EGR3 | early growth response 3 | 0.043 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.043 | ||
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.042 | ||
| PLAU | plasminogen activator, urokinase | 0.042 | Human | |
| CYBB | cytochrome b-245, beta polypeptide | 0.040 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.040 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.040 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.040 | Rat | |
| LYZ | lysozyme | 0.040 | ||
| TFEC | transcription factor EC | 0.040 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.039 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.039 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.039 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.039 | ||
| IL4R | interleukin 4 receptor | 0.038 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.037 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.036 | ||
| SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 0.036 | ||
| LST1 | leukocyte specific transcript 1 | 0.036 | ||
| FAP | fibroblast activation protein, alpha | 0.035 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.035 | ||
| FRZB | frizzled-related protein | 0.035 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.035 | ||
| GPR183 | G protein-coupled receptor 183 | 0.035 | ||
| ORM1 | orosomucoid 1 | 0.035 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.034 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.034 | ||
| GPNMB | glycoprotein (transmembrane) nmb | 0.033 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.033 | ||
| CYTIP | cytohesin 1 interacting protein | 0.033 | ||
| SPHK1 | sphingosine kinase 1 | 0.032 | ||
| CD69 | CD69 molecule | 0.031 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.031 | ||
| SLC2A14 | solute carrier family 2 (facilitated glucose transporter), member 14 | 0.031 | ||
| EVI2B | ecotropic viral integration site 2B | 0.031 | ||
| SERPINB8 | serpin peptidase inhibitor, clade B (ovalbumin), member 8 | 0.030 | ||
| TLR1 | toll-like receptor 1 | 0.030 | ||
| UPP1 | uridine phosphorylase 1 | 0.030 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.030 | ||
| HAS2 | hyaluronan synthase 2 | 0.030 | ||
| AIF1 | allograft inflammatory factor 1 | 0.030 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.030 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.029 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.029 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.029 | ||
| EGR1 | early growth response 1 | 0.028 | ||
| VTN | vitronectin | 0.027 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.027 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.027 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.027 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.027 | ||
| KIAA1377 | KIAA1377 | 0.027 | ||
| THBD | thrombomodulin | 0.026 | ||
| FST | follistatin | 0.026 | ||
| CLEC4E | C-type lectin domain family 4, member E | 0.026 | ||
| AMT | aminomethyltransferase | 0.025 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.025 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.025 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.025 | ||
| SLAMF8 | SLAM family member 8 | 0.025 | ||
| CHST11 | carbohydrate (chondroitin 4) sulfotransferase 11 | 0.024 | ||
| NPY1R | neuropeptide Y receptor Y1 | 0.024 | ||
| PRDM1 | PR domain containing 1, with ZNF domain | 0.024 | ||
| PDE4B | phosphodiesterase 4B, cAMP-specific | 0.024 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.024 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.024 | ||
| LY86 | lymphocyte antigen 86 | 0.024 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.024 | ||
| MRC1 | mannose receptor, C type 1 | 0.024 | ||
| FOSL1 | FOS-like antigen 1 | 0.023 | ||
| IL1A | interleukin 1, alpha | 0.023 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.023 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.023 | ||
| CD86 | CD86 molecule | 0.023 | ||
| HDC | histidine decarboxylase | 0.023 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.023 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.022 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.022 | ||
| IER2 | immediate early response 2 | 0.022 | ||
| CD48 | CD48 molecule | 0.022 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.022 | ||
| SELL | selectin L | 0.022 | ||
| EMR2 | egf-like module containing, mucin-like, hormone receptor-like 2 | 0.022 | ||
| IGSF6 | immunoglobulin superfamily, member 6 | 0.022 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.022 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.021 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.021 | ||
| KYNU | kynureninase | 0.021 | ||
| SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | 0.021 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.021 | ||
| GPR84 | G protein-coupled receptor 84 | 0.021 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.021 | ||
| PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 0.021 | Rat | |
| TPST1 | tyrosylprotein sulfotransferase 1 | 0.020 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.020 | ||
| TFR2 | transferrin receptor 2 | 0.020 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.020 | ||
| PDPN | podoplanin | 0.020 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.020 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.019 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.019 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.019 | ||
| FPR1 | formyl peptide receptor 1 | 0.019 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.019 | ||
| SPP1 | secreted phosphoprotein 1 | 0.019 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.019 | ||
| IL33 | interleukin 33 | 0.019 | ||
| C2 | complement component 2 | 0.019 | ||
| SNRNP35 | small nuclear ribonucleoprotein 35kDa (U11/U12) | 0.019 | ||
| PROCR | protein C receptor, endothelial | 0.019 | ||
| GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 0.019 | ||
| EREG | epiregulin | 0.019 | ||
| LOX | lysyl oxidase | 0.018 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.018 | ||
| TARP | TCR gamma alternate reading frame protein | 0.018 | ||
| IFNG | interferon, gamma | 0.018 | ||
| CD14 | CD14 molecule | 0.018 | ||
| PHAX | phosphorylated adaptor for RNA export | 0.018 | ||
| PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 0.018 | ||
| SAA4 | serum amyloid A4, constitutive | 0.018 | ||
| TACR1 | tachykinin receptor 1 | 0.018 | ||
| GCGR | glucagon receptor | 0.018 | ||
| HPGDS | hematopoietic prostaglandin D synthase | 0.018 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.018 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.018 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.017 | ||
| CRP | C-reactive protein, pentraxin-related | 0.017 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.017 | ||
| LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.017 | ||
| PTHLH | parathyroid hormone-like hormone | 0.017 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.017 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.017 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.017 | ||
| TRMT2A | TRM2 tRNA methyltransferase 2 homolog A (S. cerevisiae) | 0.017 | ||
| TLR7 | toll-like receptor 7 | 0.017 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.017 | ||
| GNLY | granulysin | 0.017 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.017 | ||
| ZC3HC1 | zinc finger, C3HC-type containing 1 | 0.016 | ||
| FGL2 | fibrinogen-like 2 | 0.016 | ||
| DARC | Duffy blood group, chemokine receptor | 0.016 | ||
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.016 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.016 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.016 | ||
| C4BPB | complement component 4 binding protein, beta | 0.016 | ||
| FGB | fibrinogen beta chain | 0.016 | ||
| HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.016 | ||
| VEGFC | vascular endothelial growth factor C | 0.016 | ||
| FPR2 | formyl peptide receptor 2 | 0.016 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.016 | ||
| CST7 | cystatin F (leukocystatin) | 0.016 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.016 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.016 | ||
| MBTPS1 | membrane-bound transcription factor peptidase, site 1 | 0.016 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.016 | ||
| GZMK | granzyme K (granzyme 3; tryptase II) | 0.015 | ||
| NKG7 | natural killer cell group 7 sequence | 0.015 | ||
| KCNJ15 | potassium inwardly-rectifying channel, subfamily J, member 15 | 0.015 | ||
| CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 | 0.015 | ||
| GHRL | ghrelin/obestatin prepropeptide | 0.015 | ||
| CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.015 | ||
| BIN2 | bridging integrator 2 | 0.015 | ||
| C7orf36 | chromosome 7 open reading frame 36 | 0.015 | ||
| DPT | dermatopontin | 0.015 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.015 | ||
| PLG | plasminogen | 0.015 | Human | |
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.015 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.015 | ||
| CSTA | cystatin A (stefin A) | 0.015 | ||
| C3 | complement component 3 | 0.014 | Mouse | |
| SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.014 | ||
| CP | ceruloplasmin (ferroxidase) | 0.014 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.014 | ||
| C9 | complement component 9 | 0.014 | ||
| BMP2 | bone morphogenetic protein 2 | 0.014 | ||
| LUM | lumican | 0.014 | ||
| MSR1 | macrophage scavenger receptor 1 | 0.014 | ||
| FFAR2 | free fatty acid receptor 2 | 0.014 | Mouse | |
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.014 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.014 | ||
| STEAP4 | STEAP family member 4 | 0.014 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.014 | ||
| CD93 | CD93 molecule | 0.014 | ||
| LAMB3 | laminin, beta 3 | 0.014 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.014 | ||
| ARHGAP15 | Rho GTPase activating protein 15 | 0.014 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.014 | ||
| IL32 | interleukin 32 | 0.014 | ||
| PTAFR | platelet-activating factor receptor | 0.014 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.014 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.014 | ||
| APOF | apolipoprotein F | 0.014 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.014 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.013 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.013 | ||
| GPR171 | G protein-coupled receptor 171 | 0.013 | ||
| TTR | transthyretin | 0.013 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.013 | ||
| C8A | complement component 8, alpha polypeptide | 0.013 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.013 | ||
| PLK3 | polo-like kinase 3 | 0.013 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.013 | ||
| IL21R | interleukin 21 receptor | 0.013 | ||
| VNN2 | vanin 2 | 0.013 | ||
| MS4A2 | membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) | 0.013 | ||
| PDGFC | platelet derived growth factor C | 0.013 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.013 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.013 | ||
| ALDH1A3 | aldehyde dehydrogenase 1 family, member A3 | 0.013 | ||
| FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | 0.013 | ||
| CPVL | carboxypeptidase, vitellogenic-like | 0.013 | ||
| LPA | lipoprotein, Lp(a) | 0.013 | Human | |
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.013 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.013 | ||
| CD27 | CD27 molecule | 0.013 | ||
| C8orf4 | chromosome 8 open reading frame 4 | 0.013 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.013 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.013 | ||
| NRP2 | neuropilin 2 | 0.013 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.012 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.012 | ||
| EDN1 | endothelin 1 | 0.012 | ||
| VNN1 | vanin 1 | 0.012 | ||
| ARG1 | arginase, liver | 0.012 | ||
| CD1C | CD1c molecule | 0.012 | ||
| HSPA6 | heat shock 70kDa protein 6 (HSP70B') | 0.012 | ||
| SLAMF7 | SLAM family member 7 | 0.012 | ||
| FCGR1B | Fc fragment of IgG, high affinity Ib, receptor (CD64) | 0.012 | Mouse | |
| S100A12 | S100 calcium binding protein A12 | 0.012 | ||
| BST1 | bone marrow stromal cell antigen 1 | 0.012 | ||
| IL13RA2 | interleukin 13 receptor, alpha 2 | 0.012 | ||
| CTSS | cathepsin S | 0.012 | ||
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.012 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.012 | ||
| KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | 0.012 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.012 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.012 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.012 | ||
| IL4 | interleukin 4 | 0.012 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.012 | ||
| PRF1 | perforin 1 (pore forming protein) | 0.012 | ||
| MPEG1 | macrophage expressed 1 | 0.012 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.012 | ||
| IL10 | interleukin 10 | 0.011 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.011 | ||
| CFHR2 | complement factor H-related 2 | 0.011 | ||
| RCAN1 | regulator of calcineurin 1 | 0.011 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.011 | ||
| MED24 | mediator complex subunit 24 | 0.011 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.011 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.011 | ||
| TAC1 | tachykinin, precursor 1 | 0.011 | Rat | |
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.011 | ||
| PIK3CG | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 0.011 | ||
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.011 | ||
| IL2RB | interleukin 2 receptor, beta | 0.011 | ||
| TNFSF15 | tumor necrosis factor (ligand) superfamily, member 15 | 0.011 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.011 | ||
| IL7 | interleukin 7 | 0.011 | ||
| SERPINF1 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 | 0.011 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.011 | ||
| B3GNT5 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 | 0.011 | ||
| CLC | Charcot-Leyden crystal protein | 0.011 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.011 | ||
| MMP19 | matrix metallopeptidase 19 | 0.011 | ||
| CLDN1 | claudin 1 | 0.011 | ||
| FPR3 | formyl peptide receptor 3 | 0.011 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.011 | Human | |
| ESM1 | endothelial cell-specific molecule 1 | 0.011 | ||
| CLEC4A | C-type lectin domain family 4, member A | 0.011 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.011 | ||
| CD84 | CD84 molecule | 0.011 | ||
| GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.011 | ||
| IRF4 | interferon regulatory factor 4 | 0.011 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.011 | ||
| OSM | oncostatin M | 0.011 | ||
| HBQ1 | hemoglobin, theta 1 | 0.011 | ||
| GPR34 | G protein-coupled receptor 34 | 0.011 | ||
| SIGLEC5 | sialic acid binding Ig-like lectin 5 | 0.011 | ||
| C4B | complement component 4B (Chido blood group) | 0.011 | ||
| PF4 | platelet factor 4 | 0.011 | ||
| KCNN4 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | 0.011 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.010 | ||
| ANXA3 | annexin A3 | 0.010 | ||
| SLC7A7 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 | 0.010 | ||
| SLPI | secretory leukocyte peptidase inhibitor | 0.010 | ||
| ADORA2A | adenosine A2a receptor | 0.010 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.010 | ||
| SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | 0.010 | ||
| SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 0.010 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.010 | ||
| BASP1 | brain abundant, membrane attached signal protein 1 | 0.010 | ||
| WNT5A | wingless-type MMTV integration site family, member 5A | 0.010 | ||
| CCR6 | chemokine (C-C motif) receptor 6 | 0.010 | ||
| PTH | parathyroid hormone | 0.010 | ||
| KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 0.010 | ||
| MSC | musculin | 0.010 | ||
| DDAH2 | dimethylarginine dimethylaminohydrolase 2 | 0.010 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.010 | ||
| ADM | adrenomedullin | 0.010 |